EntryPoint Capital’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-458	Closed	-$2.12K	–	694
2024 Q2	$2.12K	Sell	458 -28,058	-98%	-$130K	﹤0.01%	807
2024 Q1	$233K	Buy	+28,516	New	+$233K	0.21%	68